A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: Effects on arterial compliance and endothelial function

Clinical Endocrinology

Volumn 55, Issue 5, 2001, Pages 673-682

  Teede, Helena J ^a,c   Liang, Yu Lu ^a   Kotsopoulos, Dimitra ^a   Zoungas, Sophia ^a   Craven, Robyn ^b   McGrath, Barry P ^a  

^a MONASH UNIVERSITY   (Australia)

^b Jean Hailes Foundation for Women's Health   (Australia)

^c DANDENONG HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; NORETHISTERONE; PLACEBO; PROGESTERONE; TRIACYLGLYCEROL;

ADULT; ARTERY COMPLIANCE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN ACTIVITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIPOPROTEIN(A); MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; VASCULAR RESISTANCE; VASODILATION;

EID: 0035725454     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01382.x     Document Type: Article

References (49)

1. Effect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal women
2. Close correlation of endothelial function in the human coronary and peripheral circulation
3. Postmenopausal estrogen and prevention bias
4. Trends in cardiovascular risk factors in Australia. Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980-1989
5. 17Beta-oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta
6. A method of estimation of missing values in multivariate data suitable for use with an electronic computer
7. Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women
8. Estimation of arterial mechanics in clinical practice and as a research technique
9. Endothelial dysfunction: Does it matter? Is it reversible?
10. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults
11. Estrogen and progestin compared with simvastatin for hypercholes-terolemia in postmenopausal women
12. HRT compliance in women over 60
13. Personal perspective on low-dosage estrogen therapy for postmenopausal women
14. Estradiol therapy combined with progesterone and endothelium-dependent vasodila-tion in postmenopausal women
15. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle
16. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy
17. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmeno-pausal women
18. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
19. Arterial dilation and reduced wave reflection. Benefit of dilevalol in hypertension
20. Vascular effects of estrogen and cholesterol-lowering therapies in hyperch-olesterolemic postmenopausal women
21. Non-invasive measurements of arterial structure and function: Repeatability, interrelationships and trial sample size
22. Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women
23. Estimation of total arterial compliance an improved method and evaluation of current methods
24. Repeated measurements and multiple comparisons in cardiovascular research
25. Multiple comparison procedures updated
26. Lipoprotein (a) concentration and apolipoprotein (a) size. A synergistic role in advanced atherosclerosis?
27. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women
28. Age-related deterioration in arterial structure and function in postmenopausal women: The impact of hormone replacement therapy
29. Effect of fat and carbohydrate consumption on endothelial function
30. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial
31. Estrogen use and blood pressure in later life
32. Hormonal therapy increases arterial compliance in postmenopausal women
33. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
34. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: A prospective study
35. Estrogen and progestin, lipoprotein (a), and the risk of recurrent coronary heart disease events after menopause
36. Noninvasive assessment of endothelial vasomotor function
37. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
38. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
39. Arterial stiffness and hormone replacement use in healthy postmenopausal women
40. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function
41. Postmenopausal hormone replacement therapy increases both coagulation activity and fibrinolysis
42. Short-term hormone replacement therapy: Reduced plasma levels of soluble adhesion molecules
43. Oestrodiol inhibits smooth muscle cell proliferation of pig coronary artery
44. Withdrawal of hormonal therapy for 4 weeks decreases arterial compliance in postmenopausal women
45. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
46. Progestins and androgens
47. Effects of estrogens on vascular tone
48. Regression of atherosclerosis in female monkeys
49. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort